OXiGENE to present at Friedman Billings Ramsey Ninth Annual Growth Conference, Upstate introduces new red-shifted KinEASE FP Assays.

0 Comments | M2 Presswire, May, 2005

M2 PRESSWIRE-27 May 2005-US Financial Network: OXiGENE to present at Friedman Billings Ramsey Ninth Annual Growth Conference, Upstate introduces new red-shifted KinEASE FP Assays(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:27052005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU).

OXiGENE, Inc. (NASDAQ: OXGN), a leading developer of biopharmaceutical compounds designed to target aberrant blood vessels within solid tumor cancers and ocular neovascular diseases, today announced that President and Chief Executive Officer Fred Driscoll will present an overview of the Company at the Friedman Billings Ramsey Ninth Annual Growth Conference on June 1st at 11:00 am ET. Serologicals Corporation (NASDAQ: SERO) today announced...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)